Medtronic to Initiate Clinical Study Evaluating Infuse Bone Graft in TLIF Spine Procedures

Medtronic and Tidepool Collaborates to Develop Interoperable Automated Insulin Pump System for Diabetes Management


  • Medtronic has initiated site recruitment for the Transforaminal Lumbar Interbody Fusion (TLIF) clinical study to enroll up to 50 sites with over 1,000 patients. The expanded indication to use Infuse posterior spine procedures provide patients a powerful option in a spine surgeon’s armamentarium
  • Additionally, in 2017, Medtronic got approval to evaluate Infuse Bone Graft in Posterolateral Fusion (PLF) and is working with the FDA to incorporate safety & efficacy data for indication expansion in PLF
  • Medtronic continues to invest in the expansion of its Infuse Bone Graft for multiple indications. Infuse Bone Graft is an approved product for certain spine, oral-maxillofacial and orthopedic trauma surgeries and is being marketed since 2002

Click here to­ read full press release/ article | Ref: Medtronic | Image: Medtronic